Overview
- 7 inspections across 7 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-06-06.
At a glance
Inspections
7
Sites
7
Observations
0
Career since
May 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lonza Biologics, Inc. | 6 Jun 2025 | Biologics | On file |
| Janssen Pharmaceuticals Inc. | 1 Nov 2024 | Biologics | On file |
| Simtra US LLC | 26 Jul 2024 | Biologics | On file |
| Instituto Grifols, S.A. | 5 Mar 2024 | Biologics | |
| Janssen Vaccines, Zweigniederlassung der Cilag GmbH International | 18 Oct 2023 | Biologics |
Sites inspected
Lonza Biologics, Inc.Portsmouth, United States1 insp.
Janssen Pharmaceuticals Inc.Raritan, United States1 insp.
Simtra US LLCBloomington, United States1 insp.
Instituto Grifols, S.A.Parets Del Valles, Spain1 insp.
Janssen Vaccines, Zweigniederlassung der Cilag GmbH InternationalBern, Switzerland1 insp.
Co-investigators
Investigators who share inspections with this person.
Carl A Perez2 shared
Athena L Russell1 shared
Kinjal S Patel1 shared
Timothy Kamaldinov1 shared
Massoud Motamed1 shared
Kevin J Matthews1 shared
Grace I Cortesini1 shared
Andrew E Timmons1 shared
Alifiya H Ghadiali1 shared
Malgorzata G Norton1 shared
Full investigator report
Get the verbatim findings behind Xiuju Lu's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site